佛跳墙加器器2023
Our mission is to process and harmonize Alzheimer’s Disease genetic and genomic data to facilitate and expedite gene discovery and drug target identification.
佛跳墙加器器2023
Whole-genome and whole-exome sequencing data are processed into CRAMs, gVCFs and then joint called into project level VCFs.

佛跳墙加器器2023
GCAD is facilitating collaborations between cohorts and researchers studying neurodegenerative diseases from all over the world.